GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xeris Biopharma Holdings Inc (STU:2B30) » Definitions » Common Stock

Xeris Biopharma Holdings (STU:2B30) Common Stock : €0.0 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Xeris Biopharma Holdings Common Stock?

Xeris Biopharma Holdings's quarterly common stock stayed the same from Jun. 2024 (€0.0 Mil) to Sep. 2024 (€0.0 Mil) and stayed the same from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€0.0 Mil).

Xeris Biopharma Holdings's annual common stock stayed the same from Dec. 2022 (€0.0 Mil) to Dec. 2023 (€0.0 Mil) but then increased from Dec. 2023 (€0.0 Mil) to Dec. 2024 (€0.0 Mil).


Xeris Biopharma Holdings Common Stock Historical Data

The historical data trend for Xeris Biopharma Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xeris Biopharma Holdings Common Stock Chart

Xeris Biopharma Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only 0.01 0.01 0.01 0.01 0.01

Xeris Biopharma Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Xeris Biopharma Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Xeris Biopharma Holdings Business Description

Traded in Other Exchanges
Address
1375 West Fulton Street, Suite 1300, Chicago, IL, USA, 60607
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Xeris Biopharma Holdings Headlines

No Headlines